TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
56,672
|
60,329
|
53,730 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3,985
|
6,378
|
7,277 |
| EBITDA |
4,154
|
6,402
|
7,524 |
| Total assets |
14,318
|
15,531
|
20,065 |
| Current assets |
12,802
|
13,835
|
19,351 |
| Current liabilities |
9,016
|
10,395
|
15,189 |
| Equity capital |
5,302
|
5,136
|
4,876 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
14
|
14
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
37.0%
|
33.1%
|
24.3% |
| Turnover per employee |
4,048
|
4,309
|
4,133 |
| Profit as a percentage of turnover |
7.0%
|
10.6%
|
13.5% |
| Return on assets (ROA) |
27.8%
|
41.1%
|
36.3% |
| Current ratio |
142.0%
|
133.1%
|
127.4% |
| Return on equity (ROE) |
75.2%
|
124.2%
|
149.2% |
| Change turnover |
-3,657
|
6,599
|
-3,335 |
| Change turnover % |
-6%
|
12%
|
-6% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
8%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.